# Biochemical analysis reveals aberrant and variable Immunoglobulin M composition in Waldenström macroglobulinemia and IgM monoclonal gammopathy of unknown significance

**Authors:** Nienke Oskam, Wouter Verhaar, Pleuni Ooijevaar-de Heer, Karima Amaador, Ninotska I. L. Derksen, Sofie Keijzer, Marie José Kersten, Marij Streutker, Josephine M. I. Vos, Theo Rispens

PMC · DOI: 10.3389/fimmu.2025.1670408 · 2025-11-06

## TL;DR

This study shows that IgM in Waldenström macroglobulinemia and IgM MGUS has abnormal structure and function, which may explain varied symptoms in patients.

## Contribution

The study reveals structural and functional variability in pathological IgM not previously characterized in IgM gammopathies.

## Key findings

- IgM in some patients lacked the J-chain, leading to variable polymerization.
- High IgM levels were associated with reduced CD5L saturation.
- Binding to polymeric Ig receptor varied significantly between patients.

## Abstract

Waldenström Macroglobulinemia (WM) is a rare B cell malignancy defined by greater than 10% infiltration of lymphoplasmacytic cells in the bone marrow (BM) and a circulating monoclonal Immunoglobulin M (IgM), while its precursor state IgM monoclonal gammopathy of undetermined significance (MGUS) has <10% BM infiltration. WM and IgM MGUS are unique amongst malignant lymphomas because symptoms and treatment indication may be caused by monoclonal IgM and not by the malignant cell infiltration. These symptoms correlate poorly with IgM levels, suggesting there may be specific biochemical properties of those pathological IgMs, yet IgM structure in IgM gammopathies has not been systematically studied. In healthy individuals, IgM circulates as a pentameric molecule that consists of five covalently linked monomers (H2L2 pairs), a joining (J-) chain and one CD5-Like (CD5L) molecule. In order to gain insight into structural variation of IgM in monoclonal IgM gammopathies, we developed and tested several assays to determine J-chain and CD5L content and polymerization state of IgM from 29 IgM MGUS and WM patients. In multiple cases, IgM was found to be (partially) devoid of J-chain, which associated with differential assembly of IgM into variably sized polymers. Moreover, we found that IgM exceeding ~5 g/L was no longer saturated with CD5L. Relative binding of polymeric Ig receptor varied by over 30-fold. Combined, in this pilot study we demonstrate that structural and functional variation in IgM of IgM MGUS and WM is common. These aberrations in IgM structure may relate to variations in clinical phenotype in IgM monoclonal gammopathies.

## Linked entities

- **Proteins:** JCHAIN (joining chain of multimeric IgA and IgM)
- **Diseases:** Waldenström macroglobulinemia (MONDO:0100280)

## Full-text entities

- **Genes:** CD5L (CD5 molecule like) [NCBI Gene 922] {aka AIM, API6, CT-2, PRO229, SP-ALPHA, Spalpha}, JCHAIN (joining chain of multimeric IgA and IgM) [NCBI Gene 3512] {aka IGCJ, IGJ, JCH}
- **Diseases:** IgM MGUS (MESH:D008998), B cell malignancy (MESH:D016393), IgM gammopathies (MESH:C566367), malignant lymphomas (MESH:D008223), IgM monoclonal gammopathy (MESH:D010265), WM (MESH:D008258)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12631112/full.md

---
Source: https://tomesphere.com/paper/PMC12631112